Dr. Stephanie Venn-Watson

Right. You got to get it, like the head and skin.

Right. You got to get it, like the head and skin.

You're already like dosing yourself well with C15.

You're already like dosing yourself well with C15.

You're already like dosing yourself well with C15.

To your point, and that was a remarkable summary, we need about 100 to 200 milligrams per day. So if you compare that to like omega-3s, right, then you're talking more about grams.

To your point, and that was a remarkable summary, we need about 100 to 200 milligrams per day. So if you compare that to like omega-3s, right, then you're talking more about grams.

To your point, and that was a remarkable summary, we need about 100 to 200 milligrams per day. So if you compare that to like omega-3s, right, then you're talking more about grams.

That's right. So this is, to your point, it's a very low dose of C15. It's 100% bioavailable in the free fatty acid form. So we only need a small amount. And again, in order to help fortify our cell membranes and keep them strong, we need greater than 0.2% of that cell membrane needs to be C15. So we don't need a lot.

That's right. So this is, to your point, it's a very low dose of C15. It's 100% bioavailable in the free fatty acid form. So we only need a small amount. And again, in order to help fortify our cell membranes and keep them strong, we need greater than 0.2% of that cell membrane needs to be C15. So we don't need a lot.

That's right. So this is, to your point, it's a very low dose of C15. It's 100% bioavailable in the free fatty acid form. So we only need a small amount. And again, in order to help fortify our cell membranes and keep them strong, we need greater than 0.2% of that cell membrane needs to be C15. So we don't need a lot.

You know, we only need these low amounts to achieve these levels in our cell membranes. We also know, it's been remarkable, is that all these studies about all these different mechanisms, like activating AMPK, inhibiting mTOR, they're all showing the same concentrations. It's all the same amount that we need in our blood to have all of these many, you know, pleiotropic benefits.

You know, we only need these low amounts to achieve these levels in our cell membranes. We also know, it's been remarkable, is that all these studies about all these different mechanisms, like activating AMPK, inhibiting mTOR, they're all showing the same concentrations. It's all the same amount that we need in our blood to have all of these many, you know, pleiotropic benefits.

You know, we only need these low amounts to achieve these levels in our cell membranes. We also know, it's been remarkable, is that all these studies about all these different mechanisms, like activating AMPK, inhibiting mTOR, they're all showing the same concentrations. It's all the same amount that we need in our blood to have all of these many, you know, pleiotropic benefits.

So it's very consistent. The story just is so consistent on what we're intended to have to stay healthy. Now what we're saying is, hey, can we increase it and push it further? So it's like 0.4 to 0.6%. Can that help us be even healthier and live longer? And there's a big study that was done by a group at Harvard and a bunch of other teams.

So it's very consistent. The story just is so consistent on what we're intended to have to stay healthy. Now what we're saying is, hey, can we increase it and push it further? So it's like 0.4 to 0.6%. Can that help us be even healthier and live longer? And there's a big study that was done by a group at Harvard and a bunch of other teams.

So it's very consistent. The story just is so consistent on what we're intended to have to stay healthy. Now what we're saying is, hey, can we increase it and push it further? So it's like 0.4 to 0.6%. Can that help us be even healthier and live longer? And there's a big study that was done by a group at Harvard and a bunch of other teams.

And they did a large study and they showed that people who had these higher levels of instead of 0.2%, 0.4%. to 0.55% that they were less likely to develop heart disease over time. And then the longevity zones are going through an evolution, but in Sardinia, the people there who have, they live longer in part because they have a lower risk of developing heart disease, and specifically men,

And they did a large study and they showed that people who had these higher levels of instead of 0.2%, 0.4%. to 0.55% that they were less likely to develop heart disease over time. And then the longevity zones are going through an evolution, but in Sardinia, the people there who have, they live longer in part because they have a lower risk of developing heart disease, and specifically men,

And they did a large study and they showed that people who had these higher levels of instead of 0.2%, 0.4%. to 0.55% that they were less likely to develop heart disease over time. And then the longevity zones are going through an evolution, but in Sardinia, the people there who have, they live longer in part because they have a lower risk of developing heart disease, and specifically men,